AN Venture Partners
Venture capitalActively deployingTokyo · Pre-Seed–Growth · 21 people tracked
Investment thesis
AN Venture Partners bridges Japanese biotech innovation with the US startup ecosystem. The firm sources cutting-edge scientific research from Japan, one of the world's leading life sciences hubs with significant untapped biotech potential, and builds early-stage companies in the US to leverage its access to capital, talent, and industry networks. By partnering with leading global venture investors, the firm maximizes value creation while elevating the profile of Japanese science internationally.
Source: firm website, verified Jul 21, 2026.
Team · 21 people
from the firm's websitePartner at ARCH Ventures with MD, PhD, and MBA credentials.
PhD and MBA holder serving as partner.
PhD holder serving as associate.
PhD holder serving as investment manager.
PhD holder in fellow role.
PhD holder in senior associate role.
PhD holder working as analyst.
What they invest in
from 1 of 7 portfolio companiesBiotech ×1Medical Devices ×1
HQs:United States×1
Investments · 7 tracked
founders shown can be your intro pathCity Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands. The company aims to expand RNAi therapeutics beyond liver targeting to additional cell and tissue types.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)
Frequently asked questions
- What stage does AN Venture Partners invest at?
- AN Venture Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does AN Venture Partners focus on?
- AN Venture Partners focuses on Biotech.
- Where is AN Venture Partners located?
- AN Venture Partners is headquartered in Tokyo, JP.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Madrona is a venture capital firm founded in Seattle in 1995 that invests across incubation, seed, and acceleration stages (Series B/C), combining capital with hands-on partnership and operational support.